> top > docs > PMC:3585731 > spans > 7626-8164 > annotations

PMC:3585731 / 7626-8164 JSONTXT

Annnotations TAB JSON ListView MergeView

testone

Id Subject Object Predicate Lexical cue
T28489 431-438 Positive_regulation denotes induced
T28488 454-458 Protein denotes TNFα
R19753 T28488 T28489 causeOf TNFα,induced

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T28678 529-537 NN denotes PD166866
T28677 526-528 NN denotes µM
T28676 523-525 CD denotes 20
T28675 519-522 CC denotes and
T28674 510-518 NN denotes PD173074
T28673 507-509 NN denotes µM
T28672 505-506 CD denotes 2
T28671 502-504 IN denotes of
T28670 493-501 NN denotes presence
T28669 489-492 DT denotes the
T28668 486-488 IN denotes in
T28667 476-485 NN denotes condition
T28666 470-475 NN denotes serum
T28665 465-469 JJ denotes full
T28664 459-464 IN denotes under
T28663 454-458 NN denotes TNFα
T28662 451-453 CC denotes or
T28661 442-450 NN denotes zVAD.fmk
T28660 439-441 IN denotes by
T28659 431-438 VB denotes induced
T28658 427-430 VB denotes was
T28657 421-426 NN denotes death
T28656 416-420 NN denotes Cell
T28655 414-415 -RRB- denotes )
T28654 413-414 NN denotes D
T28653 412-413 -LRB- denotes (
T28652 405-411 NN denotes assay.
T28651 395-404 NN denotes viability
T28650 392-394 IN denotes by
T28649 383-391 VB denotes followed
T28648 379-382 NN denotes hrs
T28647 376-378 CD denotes 24
T28646 372-375 IN denotes for
T28645 367-371 DT denotes both
T28644 364-366 CC denotes or
T28643 362-363 -COMMA- denotes ,
T28642 354-362 NN denotes zVAD.fmk
T28641 352-353 -COMMA- denotes ,
T28640 349-352 NN denotes FGF
T28639 344-348 IN denotes with
T28638 336-343 VB denotes treated
T28637 331-335 VB denotes were
T28636 320-330 NN denotes conditions
T28635 315-319 JJ denotes free
T28634 309-314 NN denotes serum
T28633 303-308 IN denotes under
T28632 297-302 NN denotes Cells
T28631 295-296 -RRB- denotes )
T28630 294-295 NN denotes C
T28629 293-294 -LRB- denotes (
T28628 282-292 NN denotes viability.
T28627 277-281 NN denotes cell
T28626 274-276 IN denotes of
T28625 262-273 NN denotes measurement
T28624 259-261 IN denotes by
T28623 250-258 VB denotes followed
T28622 246-249 NN denotes hrs
T28621 243-245 CD denotes 24
T28620 239-242 IN denotes for
T28619 228-238 NN denotes conditions
T28618 223-227 JJ denotes free
T28617 217-222 NN denotes serum
T28616 211-216 IN denotes under
T28615 205-210 NN denotes Nec-1
T28614 201-204 CC denotes and
T28613 199-200 -COMMA- denotes ,
T28612 192-199 NN denotes factors
T28611 185-191 NN denotes growth
T28610 175-184 VB denotes indicated
T28609 171-174 DT denotes the
T28608 169-170 -COMMA- denotes ,
T28607 161-169 NN denotes zVAD.fmk
T28606 156-160 IN denotes with
T28605 148-155 VB denotes treated
T28604 143-147 VB denotes were
T28603 137-142 NN denotes Cells
T28602 135-136 -RRB- denotes )
T28601 134-135 NN denotes B
T28600 133-134 -LRB- denotes (
T28599 124-132 NN denotes figures.
T28598 120-123 DT denotes the
T28597 117-119 IN denotes in
T28596 107-116 VB denotes indicated
T28595 104-106 CC denotes or
T28594 96-103 NN denotes section
T28593 87-94 NNP denotes Methods
T28592 83-86 CC denotes and
T28591 73-82 NNP denotes Materials
T28590 68-71 DT denotes the
T28589 65-67 IN denotes in
T28588 58-64 VB denotes listed
T28587 54-57 VB denotes are
T28586 47-53 NN denotes agents
T28585 26-46 JJ denotes necroptosis-inducing
T28584 22-25 DT denotes all
T28583 19-21 IN denotes of
T28582 4-18 NN denotes concentrations
T28581 0-3 DT denotes The
R19798 T28582 T28581 arg1Of concentrations,The
R19799 T28582 T28583 arg1Of concentrations,of
R19800 T28582 T28587 arg1Of concentrations,are
R19801 T28582 T28588 arg2Of concentrations,listed
R19802 T28586 T28583 arg2Of agents,of
R19803 T28586 T28584 arg1Of agents,all
R19804 T28586 T28585 arg1Of agents,necroptosis-inducing
R19805 T28588 T28587 arg2Of listed,are
R19806 T28588 T28589 arg1Of listed,in
R19807 T28588 T28606 arg1Of listed,with
R19809 T28589 T28590 arg1Of in,the
R19810 T28591 T28592 arg1Of Materials,and
R19811 T28592 T28589 arg2Of and,in
R19812 T28592 T28604 modOf and,were
R19813 T28593 T28592 arg2Of Methods,and
R19814 T28594 T28595 arg1Of section,or
R19815 T28594 T28596 arg2Of section,indicated
R19816 T28594 T28604 arg1Of section,were
R19817 T28594 T28605 arg2Of section,treated
R19818 T28596 T28597 arg1Of indicated,in
R19819 T28601 T28600 arg2Of B,(
R19820 T28602 T28600 arg3Of ),(
R19821 T28603 T28597 arg2Of Cells,in
R19822 T28603 T28598 arg1Of Cells,the
R19823 T28603 T28599 arg1Of Cells,figures.
R19824 T28603 T28600 arg1Of Cells,(
R19825 T28605 T28604 arg2Of treated,were
R19826 T28607 T28606 arg2Of zVAD.fmk,with
R19827 T28607 T28608 arg1Of zVAD.fmk,","
R19834 T28615 T28658 arg1Of Nec-1,was
R19835 T28615 T28659 arg2Of Nec-1,induced
R19859 T28638 T28646 arg1Of treated,for
R19865 T28645 T28644 arg2Of both,or
R19866 T28648 T28646 arg2Of hrs,for
R19867 T28648 T28647 arg1Of hrs,24
R19868 T28648 T28649 arg2Of hrs,followed
R19869 T28652 T28649 arg1Of assay.,followed
R19870 T28652 T28650 arg2Of assay.,by
R19871 T28652 T28651 arg1Of assay.,viability
R19872 T28652 T28653 arg1Of assay.,(
R19873 T28654 T28653 arg2Of D,(
R19874 T28655 T28653 arg3Of ),(
R19877 T28657 T28656 arg1Of death,Cell
R19879 T28659 T28658 arg2Of induced,was
R19880 T28659 T28664 arg1Of induced,under
R19881 T28659 T28668 arg1Of induced,in
R19882 T28661 T28662 arg1Of zVAD.fmk,or
R19883 T28662 T28659 arg1Of or,induced
R19884 T28662 T28660 arg2Of or,by
R19885 T28663 T28662 arg2Of TNFα,or
R19886 T28667 T28664 arg2Of condition,under
R19887 T28667 T28665 arg1Of condition,full
R19888 T28667 T28666 arg1Of condition,serum
R19889 T28668 T28669 arg1Of in,the
R19890 T28668 T28671 arg1Of in,of
R19891 T28670 T28668 arg2Of presence,in
R19892 T28672 T28673 arg1Of 2,µM
R19893 T28674 T28672 arg1Of PD173074,2
R19894 T28674 T28675 arg1Of PD173074,and
R19895 T28675 T28668 arg3Of and,in
R19896 T28678 T28675 arg2Of PD166866,and
R19897 T28678 T28676 arg1Of PD166866,20
R19898 T28678 T28677 arg1Of PD166866,µM
R19808 T28588 T28614 arg1Of listed,and
R19828 T28612 T28608 arg2Of factors,","
R19829 T28612 T28609 arg1Of factors,the
R19830 T28612 T28610 arg2Of factors,indicated
R19831 T28612 T28611 arg1Of factors,growth
R19832 T28614 T28613 arg1Of and,","
R19833 T28615 T28616 arg1Of Nec-1,under
R19836 T28619 T28616 arg2Of conditions,under
R19837 T28619 T28617 arg1Of conditions,serum
R19838 T28619 T28618 arg1Of conditions,free
R19839 T28619 T28620 arg1Of conditions,for
R19840 T28622 T28620 arg2Of hrs,for
R19841 T28622 T28621 arg1Of hrs,24
R19842 T28622 T28623 arg2Of hrs,followed
R19843 T28625 T28623 arg1Of measurement,followed
R19844 T28625 T28624 arg2Of measurement,by
R19845 T28625 T28626 arg1Of measurement,of
R19846 T28625 T28633 arg1Of measurement,under
R19847 T28628 T28627 arg1Of viability.,cell
R19848 T28628 T28629 arg1Of viability.,(
R19849 T28630 T28629 arg2Of C,(
R19850 T28631 T28629 arg3Of ),(
R19851 T28632 T28626 arg2Of Cells,of
R19852 T28632 T28628 arg1Of Cells,viability.
R19853 T28634 T28637 modOf serum,were
R19854 T28636 T28635 arg1Of conditions,free
R19855 T28636 T28637 arg1Of conditions,were
R19856 T28636 T28638 arg2Of conditions,treated
R19857 T28638 T28637 arg2Of treated,were
R19858 T28638 T28639 arg1Of treated,with
R19860 T28640 T28641 arg1Of FGF,","
R19861 T28641 T28644 arg1Of ",",or
R19862 T28642 T28641 arg2Of zVAD.fmk,","
R19863 T28644 T28639 arg2Of or,with
R19864 T28644 T28643 arg1Of or,","
R19875 T28657 T28633 arg2Of death,under
R19876 T28657 T28634 arg1Of death,serum
R19878 T28659 T28614 arg2Of induced,and

bionlp-st-ge-2016-test-proteins

Id Subject Object Predicate Lexical cue
T28516 454-458 Protein denotes TNFα

bionlp-st-ge-2016-uniprot

Id Subject Object Predicate Lexical cue
T28693 454-458 http://www.uniprot.org/uniprot/P01375 denotes TNFα
T28691 349-352 http://www.uniprot.org/uniprot/Q788Q8 denotes FGF

UBERON-AE

Id Subject Object Predicate Lexical cue
T28503 470-475 http://purl.obolibrary.org/obo/UBERON_0001977 denotes serum
T28502 309-314 http://purl.obolibrary.org/obo/UBERON_0001977 denotes serum
T28501 217-222 http://purl.obolibrary.org/obo/UBERON_0001977 denotes serum

GO-BP

Id Subject Object Predicate Lexical cue
T28525 421-426 http://purl.obolibrary.org/obo/GO_0016265 denotes death
T28524 416-438 http://purl.obolibrary.org/obo/GO_0071888 denotes Cell death was induced
T28523 416-438 http://purl.obolibrary.org/obo/GO_0043276 denotes Cell death was induced
T28522 416-426 http://purl.obolibrary.org/obo/GO_0008219 denotes Cell death
T28521 185-191 http://purl.obolibrary.org/obo/GO_0040007 denotes growth
T28520 26-37 http://purl.obolibrary.org/obo/GO_0097528 denotes necroptosis
T28518 26-37 http://purl.obolibrary.org/obo/GO_0070266 denotes necroptosis

GO-CC

Id Subject Object Predicate Lexical cue
T28528 416-420 http://purl.obolibrary.org/obo/GO_0005623 denotes Cell

sentences

Id Subject Object Predicate Lexical cue
T28507 0-538 Sentence denotes The concentrations of all necroptosis-inducing agents are listed in the Materials and Methods section or indicated in the figures. (B) Cells were treated with zVAD.fmk, the indicated growth factors, and Nec-1 under serum free conditions for 24 hrs followed by measurement of cell viability. (C) Cells under serum free conditions were treated with FGF, zVAD.fmk, or both for 24 hrs followed by viability assay. (D) Cell death was induced by zVAD.fmk or TNFα under full serum condition in the presence of 2 µM PD173074 and 20 µM PD166866.
T50 0-538 Sentence denotes The concentrations of all necroptosis-inducing agents are listed in the Materials and Methods section or indicated in the figures. (B) Cells were treated with zVAD.fmk, the indicated growth factors, and Nec-1 under serum free conditions for 24 hrs followed by measurement of cell viability. (C) Cells under serum free conditions were treated with FGF, zVAD.fmk, or both for 24 hrs followed by viability assay. (D) Cell death was induced by zVAD.fmk or TNFα under full serum condition in the presence of 2 µM PD173074 and 20 µM PD166866.

simple1

Id Subject Object Predicate Lexical cue
T28536 454-458 Protein denotes TNFα

BioNLP16_DUT

Id Subject Object Predicate Lexical cue
T28689 454-458 Protein denotes TNFα

BioNLP16_Messiy

Id Subject Object Predicate Lexical cue
T28705 454-458 Protein denotes TNFα

DLUT931

Id Subject Object Predicate Lexical cue
T28697 454-458 Protein denotes TNFα

bionlp-st-ge-2016-test-ihmc

Id Subject Object Predicate Lexical cue
T28906 137-142 Entity denotes Cells
T28904 354-362 Entity denotes zVAD.fmk
T28903 205-210 Protein denotes Nec-1
T28901 507-518 Entity denotes µM PD173074
T28900 161-170 Entity denotes zVAD.fmk,
T28899 376-382 Protein denotes 24 hrs
T28897 442-450 Entity denotes zVAD.fmk
T28895 454-458 Protein denotes TNFα
T28894 274-291 Entity denotes of cell viability
T28892 243-291 Protein denotes 24 hrs followed by measurement of cell viability
T28889 349-352 Entity denotes FGF
T28887 297-330 Entity denotes Cells under serum free conditions

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T28865 537-538 . denotes .
T28864 529-537 NNP denotes PD166866
T28863 526-528 NNP denotes µM
T28862 523-525 CD denotes 20
T28861 519-522 CC denotes and
T28860 510-518 NNP denotes PD173074
T28859 507-509 NNP denotes µM
T28858 505-506 CD denotes 2
T28857 502-504 IN denotes of
T28856 493-501 NN denotes presence
T28855 489-492 DT denotes the
T28854 486-488 IN denotes in
T28853 476-485 NN denotes condition
T28852 470-475 NN denotes serum
T28851 465-469 JJ denotes full
T28850 459-464 IN denotes under
T28849 454-458 NNP denotes TNFα
T28848 451-453 CC denotes or
T28847 442-450 NNP denotes zVAD.fmk
T28846 439-441 IN denotes by
T28845 431-438 VBN denotes induced
T28844 427-430 VBD denotes was
T28843 421-426 NN denotes death
T28842 416-420 NNP denotes Cell
T28841 414-415 -RRB- denotes )
T28840 413-414 NNP denotes D
T28839 412-413 -LRB- denotes (
T28838 410-411 . denotes .
T28837 405-410 NN denotes assay
T28836 395-404 NN denotes viability
T28835 392-394 IN denotes by
T28834 383-391 VBN denotes followed
T28833 379-382 NNS denotes hrs
T28832 376-378 CD denotes 24
T28831 372-375 IN denotes for
T28830 367-371 DT denotes both
T28829 364-366 CC denotes or
T28828 362-363 , denotes ,
T28827 354-362 NNP denotes zVAD.fmk
T28826 352-353 , denotes ,
T28825 349-352 NNP denotes FGF
T28824 344-348 IN denotes with
T28823 336-343 VBN denotes treated
T28822 331-335 VBD denotes were
T28821 320-330 NNS denotes conditions
T28820 315-319 JJ denotes free
T28819 309-314 NN denotes serum
T28818 303-308 IN denotes under
T28817 297-302 NNS denotes Cells
T28816 295-296 -RRB- denotes )
T28815 294-295 $ denotes C
T28814 293-294 -LRB- denotes (
T28811 277-281 NN denotes cell
T28810 274-276 IN denotes of
T28809 262-273 NN denotes measurement
T28808 259-261 IN denotes by
T28807 250-258 VBN denotes followed
T28806 246-249 NNS denotes hrs
T28805 243-245 CD denotes 24
T28804 239-242 IN denotes for
T28803 228-238 NNS denotes conditions
T28802 223-227 JJ denotes free
T28801 217-222 NN denotes serum
T28800 211-216 IN denotes under
T28799 205-210 NN denotes Nec-1
T28798 201-204 CC denotes and
T28797 199-200 , denotes ,
T28796 192-199 NNS denotes factors
T28795 185-191 NN denotes growth
T28794 175-184 JJ denotes indicated
T28793 171-174 DT denotes the
T28792 169-170 , denotes ,
T28791 161-169 NNP denotes zVAD.fmk
T28790 156-160 IN denotes with
T28789 148-155 VBN denotes treated
T28788 143-147 VBD denotes were
T28787 137-142 NNPS denotes Cells
T28786 135-136 -RRB- denotes )
T28785 134-135 NNP denotes B
T28784 133-134 -LRB- denotes (
T28783 131-132 . denotes .
T28782 124-131 NNS denotes figures
T28781 120-123 DT denotes the
T28780 117-119 IN denotes in
T28779 107-116 VBN denotes indicated
T28778 104-106 CC denotes or
T28777 96-103 NN denotes section
T28776 87-94 NNPS denotes Methods
T28775 83-86 CC denotes and
T28774 73-82 NNPS denotes Materials
T28773 68-71 DT denotes the
T28772 65-67 IN denotes in
T28771 58-64 VBN denotes listed
T28770 54-57 VBP denotes are
T28769 47-53 NNS denotes agents
T28768 26-46 JJ denotes necroptosis-inducing
T28767 22-25 DT denotes all
T28766 19-21 IN denotes of
T28765 4-18 NNS denotes concentrations
T28764 0-3 DT denotes The
T28813 291-292 . denotes .
T28812 282-291 NN denotes viability
R19953 T28764 T28765 det The,concentrations
R19954 T28765 T28771 nsubjpass concentrations,listed
R19955 T28766 T28765 prep of,concentrations
R19956 T28767 T28769 det all,agents
R19957 T28768 T28769 amod necroptosis-inducing,agents
R19958 T28769 T28766 pobj agents,of
R19959 T28770 T28771 auxpass are,listed
R19960 T28771 T28771 ROOT listed,listed
R19961 T28772 T28771 prep in,listed
R19962 T28773 T28774 det the,Materials
R19963 T28774 T28772 pobj Materials,in
R19964 T28775 T28774 cc and,Materials
R19965 T28776 T28777 compound Methods,section
R19966 T28777 T28779 nsubj section,indicated
R19967 T28778 T28777 cc or,section
R19968 T28779 T28771 conj indicated,listed
R19969 T28780 T28779 prep in,indicated
R19970 T28781 T28782 det the,figures
R19971 T28782 T28780 pobj figures,in
R19972 T28783 T28779 punct .,indicated
R19973 T28784 T28785 punct (,B
R19974 T28785 T28785 ROOT B,B
R19975 T28786 T28785 punct ),B
R19976 T28787 T28789 nsubjpass Cells,treated
R19977 T28788 T28789 auxpass were,treated
R19978 T28789 T28789 ROOT treated,treated
R19979 T28790 T28789 prep with,treated
R19980 T28791 T28790 pobj zVAD.fmk,with
R19981 T28792 T28791 punct ",",zVAD.fmk
R19982 T28793 T28796 det the,factors
R19983 T28794 T28796 amod indicated,factors
R19984 T28795 T28796 compound growth,factors
R19985 T28796 T28790 pobj factors,with
R19986 T28797 T28789 punct ",",treated
R19987 T28798 T28789 cc and,treated
R19988 T28799 T28789 conj Nec-1,treated
R19989 T28800 T28799 prep under,Nec-1
R19990 T28801 T28802 npadvmod serum,free
R19991 T28802 T28803 amod free,conditions
R19992 T28803 T28800 pobj conditions,under
R19993 T28804 T28799 prep for,Nec-1
R19994 T28805 T28806 nummod 24,hrs
R19995 T28806 T28804 pobj hrs,for
R19996 T28807 T28806 acl followed,hrs
R19997 T28808 T28807 agent by,followed
R19998 T28809 T28808 pobj measurement,by
R19999 T28810 T28809 prep of,measurement
R20000 T28811 T28812 compound cell,viability
R20001 T28812 T28810 pobj viability,of
R20002 T28813 T28789 punct .,treated
R20003 T28814 T28815 punct (,C
R20004 T28815 T28815 ROOT C,C
R20005 T28816 T28815 punct ),C
R20006 T28817 T28823 nsubjpass Cells,treated
R20007 T28818 T28817 prep under,Cells
R20008 T28819 T28818 pobj serum,under
R20009 T28820 T28821 amod free,conditions
R20010 T28821 T28823 nsubjpass conditions,treated
R20011 T28822 T28823 auxpass were,treated
R20012 T28823 T28823 ROOT treated,treated
R20013 T28824 T28823 prep with,treated
R20014 T28825 T28824 pobj FGF,with
R20015 T28826 T28825 punct ",",FGF
R20016 T28827 T28825 conj zVAD.fmk,FGF
R20017 T28828 T28827 punct ",",zVAD.fmk
R20018 T28829 T28823 cc or,treated
R20019 T28830 T28831 advmod both,for
R20020 T28831 T28823 prep for,treated
R20021 T28832 T28833 nummod 24,hrs
R20022 T28833 T28831 pobj hrs,for
R20023 T28834 T28833 acl followed,hrs
R20024 T28835 T28834 agent by,followed
R20025 T28836 T28837 compound viability,assay
R20026 T28837 T28835 pobj assay,by
R20027 T28838 T28823 punct .,treated
R20028 T28839 T28845 punct (,induced
R20029 T28840 T28843 nmod D,death
R20030 T28841 T28840 punct ),D
R20031 T28842 T28843 compound Cell,death
R20032 T28843 T28845 nsubjpass death,induced
R20033 T28844 T28845 auxpass was,induced
R20034 T28845 T28845 ROOT induced,induced
R20035 T28846 T28845 agent by,induced
R20036 T28847 T28846 pobj zVAD.fmk,by
R20037 T28848 T28847 cc or,zVAD.fmk
R20038 T28849 T28847 conj TNFα,zVAD.fmk
R20039 T28850 T28845 prep under,induced
R20040 T28851 T28853 amod full,condition
R20041 T28852 T28853 compound serum,condition
R20042 T28853 T28850 pobj condition,under
R20043 T28854 T28845 prep in,induced
R20044 T28855 T28856 det the,presence
R20045 T28856 T28854 pobj presence,in
R20046 T28857 T28856 prep of,presence
R20047 T28858 T28860 nummod 2,PD173074
R20048 T28859 T28860 compound µM,PD173074
R20049 T28860 T28857 pobj PD173074,of
R20050 T28861 T28860 cc and,PD173074
R20051 T28862 T28864 nummod 20,PD166866
R20052 T28863 T28864 compound µM,PD166866
R20053 T28864 T28860 conj PD166866,PD173074
R20054 T28865 T28845 punct .,induced

bionlp-st-ge-2016-test-tees

Id Subject Object Predicate Lexical cue
T28716 526-537 Protein denotes µM PD166866
T28715 507-518 Protein denotes µM PD173074
T28714 442-458 Protein denotes zVAD.fmk or TNFα
T28713 354-362 Protein denotes zVAD.fmk
T28712 349-352 Protein denotes FGF
T28711 205-210 Protein denotes Nec-1

test3

Id Subject Object Predicate Lexical cue
T28498 454-458 Protein denotes TNFα
T28497 431-438 Positive_regulation denotes induced
T28493 454-458 Protein denotes TNFα